1887

Abstract

In this study, a serotype-specific monoclonal antibody (mAb), D 16-1 (Ab4), against dengue virus type 2 (DEN-2) was generated. The specificity of Ab4, which recognized DEN-2 non-structural protein 1, was determined by ELISA, immunofluorescence and immunoblotting analyses. The serotype-specific B-cell epitope of Ab4 was identified further from a random phage-displayed peptide library; selected phage clones reacted specifically with Ab4 and did not react with other mAbs. Immunopositive phage clones displayed a consensus motif, His–Arg/Lys–Leu/Ile, and a synthetic peptide corresponding to the phage-displayed peptide bound specifically to Ab4. The His and Arg residues in this epitope were found to be crucial for peptide binding to Ab4 and binding activity decreased dramatically when these residues were changed to Leu. The epitope-based synthetic peptide not only identified serum samples from DEN-2-immunized mice and rabbits by ELISA but also differentiated clearly between serum samples from DEN-2- and Japanese encephalitis virus-immunized mice. This mAb and its epitope-based peptide antigen will be useful for serologic diagnosis of DEN-2 infection. Furthermore, DEN-2 epitope identification makes it feasible to dissect antibody responses to DEN and to address the role of antibodies in the pathogenesis of primary and secondary DEN-2 infections.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19228-0
2003-10-01
2019-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/10/vir842771.html?itemId=/content/journal/jgv/10.1099/vir.0.19228-0&mimeType=html&fmt=ahah

References

  1. Aaskov, J. G., Geysen, H. M. & Mason, T. J. ( 1989; ). Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409). Arch Virol 105, 209–221.[CrossRef]
    [Google Scholar]
  2. Akeson, A. L., Woods, C. W., Hsieh, L. C. & 8 other authors ( 1996; ). AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J Biol Chem 271, 30517–30523.[CrossRef]
    [Google Scholar]
  3. Arap, W., Pasqualini, R. & Ruoslahti, E. ( 1998; ). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377–380.[CrossRef]
    [Google Scholar]
  4. Arap, W., Haedicke, W., Bernasconi, M. & 7 other authors ( 2002; ). Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A 99, 1527–1531.[CrossRef]
    [Google Scholar]
  5. Atwell, S., Ultsch, M., De Vos, A. M. & Wells, J. A. ( 1997; ). Structural plasticity in a remodeled protein–protein interface. Science 278, 1125–1128.[CrossRef]
    [Google Scholar]
  6. Barlow, D. J., Edwards, M. S. & Thornton, J. M. ( 1986; ). Continuous and discontinuous protein antigenic determinants. Nature 322, 747–748.[CrossRef]
    [Google Scholar]
  7. Barry, M. A., Dower, W. J. & Johnston, S. A. ( 1996; ). Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 2, 299–305.[CrossRef]
    [Google Scholar]
  8. Bielefeldt-Ohmann, H. ( 1997; ). Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol 5, 409–413.[CrossRef]
    [Google Scholar]
  9. Bottger, V., Bottger, A., Howard, S. F., Picksley, S. M., Chene, P., Garcia-Echeverria, C., Hochkeppel, H. K. & Lane, D. P. ( 1996; ). Identification of novel mdm2 binding peptides by phage display. Oncogene 13, 2141–2147.
    [Google Scholar]
  10. Bottger, A., Bottger, V., Sparks, A., Liu, W. L., Howard, S. F. & Lane, D. P. ( 1997; ). Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr Biol 7, 860–869.[CrossRef]
    [Google Scholar]
  11. Bradford, M. M. ( 1976; ). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254.[CrossRef]
    [Google Scholar]
  12. Castano, A. R., Tangri, S., Miller, J. E., Holcombe, H. R., Jackson, M. R., Huse, W. D., Kronenberg, M. & Peterson, P. A. ( 1995; ). Peptide binding and presentation by mouse CD1. Science 269, 223–226.[CrossRef]
    [Google Scholar]
  13. Cortese, R., Felici, F., Galfre, G., Luzzago, A., Monaci, P. & Nicosia, A. ( 1994; ). Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol 12, 262–267.[CrossRef]
    [Google Scholar]
  14. DeLeo, F. R., Yu, L., Burritt, J. B., Loetterle, L. R., Bond, C. W., Jesaitis, A. J. & Quinn, M. T. ( 1995; ). Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Proc Natl Acad Sci U S A 92, 7110–7114.[CrossRef]
    [Google Scholar]
  15. D'Mello, F., Partidos, C. D., Steward, M. W. & Howard, C. R. ( 1997; ). Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries. Virology 237, 319–326.[CrossRef]
    [Google Scholar]
  16. Essler, M. & Ruoslahti, E. ( 2002; ). Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci U S A 99, 2252–2257.[CrossRef]
    [Google Scholar]
  17. Felici, F., Luzzago, A., Folgori, A. & Cortese, R. ( 1993; ). Mimicking of discontinuous epitopes by phage-displayed peptides. II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries. Gene 128, 21–27.[CrossRef]
    [Google Scholar]
  18. Folgori, A., Tafi, R., Meola, A., Felici, F., Galfre, G., Cortese, R., Monaci, P. & Nicosia, A. ( 1994; ). A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J 13, 2236–2243.
    [Google Scholar]
  19. Fu, Y., Shearing, L. N., Haynes, S., Crewther, P., Tilley, L., Anders, R. F. & Foley, M. ( 1997; ). Isolation from phage display libraries of single chain variable fragment antibodies that recognize conformational epitopes in the malaria vaccine candidate, apical membrane antigen-1. J Biol Chem 272, 25678–25684.[CrossRef]
    [Google Scholar]
  20. Gubler, D. J. ( 1998; ). Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11, 480–496.
    [Google Scholar]
  21. Gubler, D. J. & Clark, G. G. ( 1995; ). Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1, 55–57.[CrossRef]
    [Google Scholar]
  22. Halstead, S. B. ( 1988; ). Pathogenesis of dengue: challenges to molecular biology. Science 239, 476–481.[CrossRef]
    [Google Scholar]
  23. Halstead, S. B., Venkateshan, C. N., Gentry, M. K. & Larsen, L. K. ( 1984; ). Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol 132, 1529–1532.
    [Google Scholar]
  24. Heiskanen, T., Lundkvist, A., Vaheri, A. & Lankinen, H. ( 1997; ). Phage-displayed peptide targeting on the Puumala hantavirus neutralization site. J Virol 71, 3879–3885.
    [Google Scholar]
  25. Henchal, E. A. & Putnak, J. R. ( 1990; ). The dengue viruses. Clin Microbiol Rev 3, 376–396.
    [Google Scholar]
  26. Innis, B. L., Thirawuth, V. & Hemachudha, C. ( 1989; ). Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus. Am J Trop Med Hyg 40, 676–687.
    [Google Scholar]
  27. Kohler, G. & Milstein, C. ( 1975; ). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497.[CrossRef]
    [Google Scholar]
  28. Koivunen, E., Arap, W., Rajotte, D., Lahdenranta, J. & Pasqualini, R. ( 1999; ). Identification of receptor ligands with phage display peptide libraries. J Nucl Med 40, 883–888.
    [Google Scholar]
  29. Kraft, S., Diefenbach, B., Mehta, R., Jonczyk, A., Luckenbach, G. A. & Goodman, S. L. ( 1999; ). Definition of an unexpected ligand recognition motif for α v β 6 integrin. J Biol Chem 274, 1979–1985.[CrossRef]
    [Google Scholar]
  30. Lam, S. K. & Devine, P. L. ( 1998; ). Evaluation of capture ELISA and rapid immunochromatographic test for the determination of IgM and IgG antibodies produced during dengue infection. Clin Diagn Virol 10, 75–81.[CrossRef]
    [Google Scholar]
  31. Laver, W. G., Air, G. M., Webster, R. G. & Smith-Gill, S. J. ( 1990; ). Epitopes on protein antigens: misconceptions and realities. Cell 61, 553–556.[CrossRef]
    [Google Scholar]
  32. Li, B., Tom, J. Y., Oare, D., Yen, R., Fairbrother, W. J., Wells, J. A. & Cunningham, B. C. ( 1995; ). Minimization of a polypeptide hormone. Science 270, 1657–1660.[CrossRef]
    [Google Scholar]
  33. Mason, P. W., Zugel, M. U., Semproni, A. R., Fournier, M. J. & Mason, T. L. ( 1990; ). The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli. J Gen Virol 71, 2107–2114.[CrossRef]
    [Google Scholar]
  34. Mazzucchelli, L., Burritt, J. B., Jesaitis, A. J., Nusrat, A., Liang, T. W., Gewirtz, A. T., Schnell, F. J. & Parkos, C. A. ( 1999; ). Cell-specific peptide binding by human neutrophils. Blood 93, 1738–1748.
    [Google Scholar]
  35. Megret, F., Hugnot, J. P., Falconar, A. & 8 other authors ( 1992; ). Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187, 480–491.[CrossRef]
    [Google Scholar]
  36. Nord, K., Gunneriusson, E., Ringdahl, J., Stahl, S., Uhlen, M. & Nygren, P. A. ( 1997; ). Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain. Nat Biotechnol 15, 772–777.
    [Google Scholar]
  37. Pasqualini, R. & Ruoslahti, E. ( 1996; ). Organ targeting in vivo using phage display peptide libraries. Nature 380, 364–366.[CrossRef]
    [Google Scholar]
  38. Pasqualini, R., Koivunen, E. & Ruoslahti, E. ( 1995; ). A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol 130, 1189–1196.[CrossRef]
    [Google Scholar]
  39. Prezzi, C., Nuzzo, M., Meola, A., Delmastro, P., Galfre, G., Cortese, R., Nicosia, A. & Monaci, P. ( 1996; ). Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J Immunol 156, 4504–4513.
    [Google Scholar]
  40. Rajotte, D. & Ruoslahti, E. ( 1999; ). Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display. J Biol Chem 274, 11593–11598.[CrossRef]
    [Google Scholar]
  41. Roehrig, J. T., Johnson, A. J., Hunt, A. R., Bolin, R. A. & Chu, M. C. ( 1990; ). Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology 177, 668–675.[CrossRef]
    [Google Scholar]
  42. Roehrig, J. T., Bolin, R. A. & Kelly, R. G. ( 1998; ). Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246, 317–328.[CrossRef]
    [Google Scholar]
  43. Scott, J. K. & Smith, G. P. ( 1990; ). Searching for peptide ligands with an epitope library. Science 249, 386–390.[CrossRef]
    [Google Scholar]
  44. Sela, M. ( 1969; ). Antigenicity: some molecular aspects. Science 166, 1365–1374.[CrossRef]
    [Google Scholar]
  45. Smith, W. C., McDowell, J. H., Dugger, D. R., Miller, R., Arendt, A., Popp, M. P. & Hargrave, P. A. ( 1999; ). Identification of regions of arrestin that bind to rhodopsin. Biochemistry 38, 2752–2761.[CrossRef]
    [Google Scholar]
  46. Strauss, E. G., Stec, D. S., Schmaljohn, A. L. & Strauss, J. H. ( 1991; ). Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants. J Virol 65, 4654–4664.
    [Google Scholar]
  47. Szardenings, M., Tornroth, S., Mutulis, F., Muceniece, R., Keinanen, K., Kuusinen, A. & Wikberg, J. E. ( 1997; ). Phage display selection on whole cells yields a peptide specific for melanocortin receptor 1. J Biol Chem 272, 27943–27948.[CrossRef]
    [Google Scholar]
  48. Tam, J. P. & Zavala, F. ( 1989; ). Multiple antigen peptide: a novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. J Immunol Methods 124, 53–61.[CrossRef]
    [Google Scholar]
  49. Trirawatanapong, T., Chandran, B., Putnak, R. & Padmanabhan, R. ( 1992; ). Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody. Gene 116, 139–150.[CrossRef]
    [Google Scholar]
  50. Vaughn, D. W., Nisalak, A., Kalayanarooj, S., Solomon, T., Dung, N. M., Cuzzubbo, A. & Devine, P. L. ( 1998; ). Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J Clin Microbiol 36, 234–238.
    [Google Scholar]
  51. Vaughn, D. W., Nisalak, A., Solomon, T., Kalayanarooj, S., Nguyen, M. D., Kneen, R., Cuzzubbo, A. & Devine, P. L. ( 1999; ). Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 60, 693–698.
    [Google Scholar]
  52. Westaway, E. G. & Blok, J. ( 1997; ). Taxonomy and evolutionary relationships of flaviviruses. In Dengue and Dengue Hemorrhagic Fever, pp. 147–173. Edited by D. J. Gubler & G. Kuno. New York: CAB International.
  53. Wrighton, N. C., Farrell, F. X., Chang, R. & 7 other authors ( 1996; ). Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273, 458–463.[CrossRef]
    [Google Scholar]
  54. Wu, H. C., Huang, Y. L., Chao, T. T., Jan, J. T., Huang, J. L., Chiang, H. Y., King, C. C. & Shaio, M. F. ( 2001a; ). Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients. J Clin Microbiol 39, 977–982.[CrossRef]
    [Google Scholar]
  55. Wu, H. C., Yeh, C. T., Huang, Y. L., Tarn, L. J. & Lung, C. C. ( 2001b; ). Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A. Appl Environ Microbiol 67, 3201–3207.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19228-0
Loading
/content/journal/jgv/10.1099/vir.0.19228-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error